Millipore Sigma Vibrant Logo

196440 Batimastat - CAS 130370-60-4 - Calbiochem

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
130370-60-4C₂₃H₃₁N₃O₄S₂

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
196440-5MG
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Glasflasche 5 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      Description
      OverviewA Marimastat (Cat. No. 444289) type of peptidyl hydroxamate-based inhibitor that potently inhibits a broad-spectrum of metalloproteinases, including MMP-1, MMP-2, MMP-3/stromelysin, MMP-7/matrilysin, MMP-9, ΔMT1 (MMP-14 without TM domain), ADAM8, and ADAM17/TACE (IC50 = 3, 4, 20, 6, 4, 2.08, 51.3, and 19 nM, respectively), by targeting both the substrate binding site and the active-site Zn2+, while being much less potent toward ACE (Angiotensin Converting Enzyme) or α-secretase (IC50 = 1.6 and 3.3 µM, respectively). Batimastat is widely used in studying the involvement of MMPs in cancinogenesis and non-cancer pathological processes both in cultures in vitro and in animals in vivo. Also available as a 25 mM solution in DMSO (Cat. No. 508408).
      Catalogue Number196440
      Brand Family Calbiochem®
      Synonyms(4-N-Hydroxyamino)-2R-isobutyl-3S-(thienylthiomethyl)succinyl)-L-phenylalanine-N-methylamide, BB-94
      References
      ReferencesSchlomann, U., et al. 2002. J. Biol. Chem. 277, 48210.
      Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
      Parvathy, S., et al. 1998. Biochemistry 37, 1680.
      Parvathy, S., et al. 1998. FEBS Lett. 431, 63.
      Yamamoto, M., et al. 1998. J. Med. Chem. 41, 1209.
      Moss, M.L., et al. 1997. Nature 385, 733.
      Eccles, S.A., et al. 1996. Cancer Res. 56, 2815.
      Brown, P.D. 1995. Advan. Enzyme Regul. 35, 293.
      Wang, X., et al. 1994. Cancer Res. 54, 4726.
      Davies, B., et al. 1993. Cancer Res. 53, 2087.
      Product Information
      CAS number130370-60-4
      FormOff-white solid
      Hill FormulaC₂₃H₃₁N₃O₄S₂
      Chemical formulaC₂₃H₃₁N₃O₄S₂
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationBatimastat, CAS 130370-60-4, is a potent inhibitor of a several metalloproteinases, including MMP-1, 2, 3, 7, 9, ΔMT1, ADAM8 & ADAM17/TACE (IC50 = 3, 4, 20, 6, 4, 2.08, 51.3 & 19 nM, respectively).
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      196440-5MG 04055977206500

      Documentation

      Batimastat - CAS 130370-60-4 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Batimastat - CAS 130370-60-4 - Calbiochem Analysenzertifikate

      TitelChargennummer
      196440

      Literatur

      Übersicht
      Schlomann, U., et al. 2002. J. Biol. Chem. 277, 48210.
      Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
      Parvathy, S., et al. 1998. Biochemistry 37, 1680.
      Parvathy, S., et al. 1998. FEBS Lett. 431, 63.
      Yamamoto, M., et al. 1998. J. Med. Chem. 41, 1209.
      Moss, M.L., et al. 1997. Nature 385, 733.
      Eccles, S.A., et al. 1996. Cancer Res. 56, 2815.
      Brown, P.D. 1995. Advan. Enzyme Regul. 35, 293.
      Wang, X., et al. 1994. Cancer Res. 54, 4726.
      Davies, B., et al. 1993. Cancer Res. 53, 2087.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-August-2010 RFH
      Synonyms(4-N-Hydroxyamino)-2R-isobutyl-3S-(thienylthiomethyl)succinyl)-L-phenylalanine-N-methylamide, BB-94
      DescriptionA Marimastat (Cat. No. 444289) type of peptidyl hydroxamate-based inhibitor that potently inhibits a broad-spectrum of metalloproteinases, including MMP-1, MMP-2, MMP-3/stromelysin, MMP-7/matrilysin, MMP-9, ΔMT1 (MMP-14 without TM domain), ADAM8, and ADAM17/TACE (IC50 = 3, 4, 20, 6, 4, 2.08, 51.3, and 19 nM, respectively), by targeting both the substrate binding site and the active-site Zn2+, while being much less potent toward ACE (Angiotensin Converting Enzyme) or α-secretase (IC50 = 1.6 and 3.3 µM, respectively). Batimastat is widely used in studying the involvement of MMPs in cancinogenesis and non-cancer pathological processes both in cultures in vitro and in animals in vivo.
      FormOff-white solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number130370-60-4
      Chemical formulaC₂₃H₃₁N₃O₄S₂
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (50 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesSchlomann, U., et al. 2002. J. Biol. Chem. 277, 48210.
      Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
      Parvathy, S., et al. 1998. Biochemistry 37, 1680.
      Parvathy, S., et al. 1998. FEBS Lett. 431, 63.
      Yamamoto, M., et al. 1998. J. Med. Chem. 41, 1209.
      Moss, M.L., et al. 1997. Nature 385, 733.
      Eccles, S.A., et al. 1996. Cancer Res. 56, 2815.
      Brown, P.D. 1995. Advan. Enzyme Regul. 35, 293.
      Wang, X., et al. 1994. Cancer Res. 54, 4726.
      Davies, B., et al. 1993. Cancer Res. 53, 2087.